Article

ASCRS 2023: Manifestations of chronic renal insufficiency in the eye

Author(s):

Umida F. Mavlyanova, PhD, in a presentation at the American Society for Cataract and Refractive Surgery’s annual meeting in San Diego, detailed how patients diagnosed with end-stage chronic renal failure displayed deceased blood flow in the orbital artery, the central artery of the retina and the posterior short ciliary arteries.

a scientific picture of the kidney. (Image Credit: AdobeStock/Crystal light)

(Image Credit: AdobeStock/Crystal light)

The status of the kidneys are reflected in the ocular parameters in patients with chronic renal insufficiency, according to research by Umida F. Mavlyanova, PhD, from the Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery, Tashkent, Uzbekistan.

Mavlyanova conducted a study that included 90 patients with end-stage chronic renal failure based on color ultrasound dopplerography, which also was used to study the blood flow of the orbital artery, central retinal artery and posterior short ciliary arteries.

Twenty healthy individuals served as controls in the study.

Mavlyanova also measured the maximum systolic velocity (Vmax) and the final diastolic velocity (Vmin) of the blood flow, and the resistance index (RI). In addition, clinical and laboratory evaluations were performed that included measurement of the blood pressure, hemoglobin, creatinine, and blood urea levels.

The results indicated that in the orbital artery, central retinal artery, and the posterior short ciliary arteries, the Vmax and Vmin were decreased significantly compared with normal values; the RI increased significantly in all areas (p<0.05 for all comparisons).

“In patients with chronic renal insufficiency, there is a violation of hemodynamic parameters of blood flow in the form of a decrease in the maximum linear velocity of blood flow in the orbital artery, the central artery of the retina and the posterior short ciliary arteries and an increase in the resistance index of the vessels of the eye,” Mavlyanova concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.